Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
enGene Holdings (ENGN) has shared an update.
Ronald H.W. Cooper has been appointed as the new CEO of enGene Holdings Inc., effective July 22, 2024, following the planned departure of the former CEO, Jason D. Hanson. Cooper brings a wealth of experience from his previous leadership roles, including his tenure as CEO of Albireo Pharma, Inc., and is set to earn a substantial salary and bonus, along with a significant stock option grant as part of his employment agreement. Alongside Cooper’s appointment, Dr. Raj Pruthi has been promoted to Chief Medical Officer, succeeding Dr. Richard Bryce. The company’s transitions and inducements aim to secure strong leadership and maintain the company’s strategic direction in the biotech industry.
For detailed information about ENGN stock, go to TipRanks’ Stock Analysis page.
